Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Gliosarcoma 3Glioma 3Glioblastoma 3Dendritic Cell Sarcoma, Interdigitating 3Oligodendroglioma 2Astrocytoma 2Sarcoma, Kaposi 1Recurrence 1Neuroectodermal Tumors, Primitive 1Meningioma 1Lymphoma 1Histiocytosis, Langerhans-Cell 1Histiocytic Sarcoma 1Heart Failure 1HIV Infections 1Erdheim-Chester Disease 1Ependymoma 1Central Nervous System Neoplasms 1Cardiotoxicity 1Brain Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

Temozolomide 58Radiotherapy 50Carmustine 23Carboplatin 18Filgrastim 17Chemotherapy, Adjuvant 17Irinotecan 12Surgical Procedures, Operative 11Peripheral Blood Stem Cell Transplantation 11O(6)-benzylguanine 10Magnetic Resonance Spectroscopy 10Drug Therapy 10Etoposide 9sargramostim 8Thiotepa 8Thalidomide 8Cyclophosphamide 8Bevacizumab 8Procarbazine 7Gene Expression Profiling 7Erlotinib Hydrochloride 7Radiation 6Everolimus 6Cisplatin 6motexafin gadolinium 5aldesleukin 5Topotecan 5Imatinib Mesylate 5Celecoxib 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Lenalidomide × Sarcoma × Clear all
NCT00036894 2015-04-30

CC-5013 in Treating Patients With Recurrent Glioma

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡